Biotage
169,3 SEK -5,89%1 investor følger denne virksomhed
Biotage is active in biotechnology. The company provides solutions in chromatography, organic synthesis, and sample preparation. The company has operations on a global level, mainly concentrated in Europe, North America, and Asia, and a large part of the projects are also conducted in collaboration with other players in the said market. Customers are found in health and care, as well as in the food industry.
Omsætning
1,86 mia.
EBIT %
16,86 %
P/E
50,69
Udbytteafkast, %
0,95 %
Kursmål
-
Anbefaling
-
Opdateret
-
NASDAQ Stockholm
BIOT
Daglig lav / høj pris
156,7 / 176
SEK
Markedsværdi
13,71 mia. SEK
Aktieomsætning
101,09 mio. SEK
Volumen
599 t
Seneste videoer
Finanskalender
Delårsrapport
23.10.2024
Årsrapport
19.02.2025
Generalforsamling
24.04.2025
Delårsrapport
24.04.2025
Delårsrapport
16.07.2025
Større aktionærerKilde: Millistream Market Data AB
Ejer | Kapital | Stemmer |
---|---|---|
Gamma Biosciences | 16,9 % | 17,0 % |
SEB Fonder | 7,6 % | 7,7 % |
Didner & Gerge Fonder | 7,2 % | 7,2 % |
Första AP-Fonden | 4,5 % | 4,6 % |
Invesco | 4,2 % | 4,2 % |
Handelsbanken Fonder | 3,7 % | 3,7 % |
Fjärde AP-Fonden | 3,3 % | 3,3 % |
Norges Bank | 3,2 % | 3,2 % |
Swedbank Robur Fonder | 3,1 % | 3,1 % |
Vanguard | 2,6 % | 2,6 % |
ViserAlle indholdstyper
Biotage AB (publ) Interim report January-September 2024
Biotage appoints Nomination Committee
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools